Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss [Phase 1]
Phase 1 study of AG-270 in participants with MTAP-deleted advanced solid tumors or lymphoma has been terminated.
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients. [EARLY_Phase 1]
An early-phase exploratory trial evaluating the safety and efficacy of intravenous Anti-CD20/CD30-CAR-T cell therapy in relapsed/refractory …
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001) [Phase 1]
Phase 1 study of MK-2118 given as intratumoral monotherapy or in combination with pembrolizumab, and of subcutaneous MK-2118 in combination …
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Comparative Quantification of MTX and Its Metabolites Post Glucarpidase
This completed clinical trial evaluated the pharmacokinetics of methotrexate and its metabolites after glucarpidase administration in patien…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. [Phase 1]
A Phase 1 study evaluating GRC 54276 in participants with advanced solid tumors and lymphomas is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Astragalus for Symptomatic Alleviation in High-grade Lymphoma [Phase 3]
A Phase 3 clinical trial is evaluating astragalus for symptomatic relief in high-grade lymphoma, with recruitment not yet started.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 multiple ascending dose study of milademetan in adults with advanced solid tumors or lymphomas has completed, and results have been …
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma [Phase 2]
Phase 2 trial evaluating whether a hypertension intervention reduces osteonecrosis in children with acute lymphoblastic leukemia or lymphoma…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma [NA]
This document provides an update on a clinical trial evaluating whole-body diffusion-weighted MRI for staging and predicting treatment respo…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the TEAM conditioning regimen (thiotepa, etoposide, cytarabine (Cytosar), melphalan) for autologous stem…
-
CLINICAL_TRIALS other · 2024-07-09Clinical Trial Update: Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors [Phase 1]
Phase I dose-escalation study and pharmacokinetic assessment of mitoxantrone hydrochloride liposome in children with relapsed/refractory lym…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) [Phase 2]
Phase 2 clinical trial PRONTO studies prophylactic versus on-demand use of tocilizumab, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Precision Medicine for Patients With Identified Actionable Mutations [Phase 2]
A Phase 2 precision medicine trial for patients with identified actionable mutations in solid tumors, lymphoma, and multiple myeloma was ter…
-
CLINICAL_TRIALS other · 2024-07-01Clinical Trial Update: Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma [Phase 1]
Reports that the Phase 1 trial of TJ011133 in relapsed/refractory advanced Solid Tumor and Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Phase I/II Study of Avelumab in Pediatric Cancer Participants [Phase 1]
A Phase I/II pediatric trial of avelumab in refractory or relapsed solid tumors and lymphoma was terminated, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E) [Phase 2]
Phase 2 MATCH subprotocol evaluating AZD9291 (osimertinib) as a targeted treatment for cancers with EGFR genetic changes; the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1) [Phase 2]
Phase 2 trial evaluating Erdafitinib (JNJ-42756493) for cancers with FGFR amplifications; the study includes advanced and refractory lymphom…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: CPAP or BiPAP for Motion Mitigation During Radiotherapy [NA]
A University Medical Center Groningen trial is evaluating CPAP or BiPAP to mitigate motion during radiotherapy for NSCLC and other cancers, …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase)
Update on the DOLPHIN-VIVO trial assessing in vivo diagnosis of lymphoma during the ex vivo phase.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT [Phase 2]
A Phase 2 trial evaluates MIT-001 for prevention of oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy [NA]
A completed clinical trial evaluating the feasibility of a digital health coaching program for individuals after CAR T-cell therapy.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients [NA]
This clinical trial update notes the completion of a study evaluating Elly, a mobile audio companion, intended to reduce anxiety in cancer p…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Establishing Prospective Mediastinal Tumor Database of PUMCH
A prospective Mediastinal Tumor Database is being established at Peking Union Medical College Hospital, enrolling cases of thymic epithelial…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and preliminary efficacy of combining surufatinib with gemcitabine in pediatric, adolesc…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating simultaneous hyperpolarized [1-13C]pyruvate and 18F-FDG PET/MRS in cancer patients is currently enrollin…